Robert Gluckman, MD, MACP, from Providence Health Plan, spoke about how medicine and pharmacist interaction can be cost-effective.
In an interview regarding the Newport Beach Institute for Value Based Medicine® conference, Robert Gluckman, MD, MACP, chief medical officer, Providence Health Plan, talked about what he wanted the key takeaways to be as well as how Providence Health Plan reduces cost in medicine and pharmacist interactions.
Transcript
What do you think the role of Providence Health Plan is in making medicine and pharmacist interactions cost-effective?
So one of the things we've done at Providence Health Plan has actually helped support providers, especially primary care practices, with embedded pharmacists. So that can help facilitate ensuring that providers are prescribing effective care, but also informing those providers around payer policy, so that we can reduce the abrasion around denials and make sure that patients can get the care they need as quickly as possible.
What do you want attendees to take away from the IVBM?
I think the biggest thing I wanted people to take away is there is so much opportunity and benefit for the new advances that pharmacy is bringing to the market. And at the same time, we also have this incredible responsibility on how to make things affordable for people. It's going to take a lot of creativity to think about how we're able to bring some of these really important advances but do it in a way that's responsible for society.
Oncology Onward: A Conversation With Thyme Care CEO and Cofounder Robin Shah
October 2nd 2023Robin Shah, CEO of Thyme Care, which he founded in 2020 with Bobby Green, MD, president and chief medical officer, joins hosts Emeline Aviki, MD, MBA, and Stephen Schleicher, MD, MBA, to discuss his evolution as an entrepreneur in oncology care innovation and his goal of positively changing how patients experience the cancer system.
Listen
Contributor: More Informed Management of Preeclampsia Is Necessary
November 29th 2023At present, it is difficult for clinicians to identify patients at greatest risk for developing preeclampsia with severe features and tailor treatment plans for them; this difficulty increases costs significantly.
Read More
Nathan Walcker Discusses Value-Based Oncology Care Initiatives at FCS
September 8th 2023Nathan Walcker, CEO at Florida Cancer Specialists & Research Institute (FCS), highlights some of the recent partnerships and initiatives at FCS to improve community-based oncology care from a value-based perspective.
Listen
Allegations call out restrictions on medically necessary care; CDC data highlight surge in COVID-19 deaths and hospitalizations; failure to include additional Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) aid raises concerns over food access.
Read More